Kilitch Drugs (India) Limited (NSE:KILITCH)

Kilitch Drugs (India) Revenue

Kilitch Drugs (India) had revenue of 431.40M INR in the quarter ending June 30, 2025, with 28.96% growth. This brings the company's revenue in the last twelve months to 2.08B, up 37.51% year-over-year. In the fiscal year ending March 31, 2025, Kilitch Drugs (India) had annual revenue of 1.98B with 28.47% growth.

• Revenue (ttm): 2.08B
• Revenue Growth: +37.51%
• P/S Ratio: 2.79
• Revenue / Employee: 11.12M
• Employees: 168
• Market Cap: 5.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.98B	439.46M	28.47%
Mar 31, 2024	1.54B	147.74M	10.58%
Mar 31, 2023	1.40B	253.65M	22.20%
Mar 31, 2022	1.14B	457.11M	66.71%
Mar 31, 2021	685.23M	152.03M	28.51%